WMS Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,275	Closed	-$272K	–	243
2017 Q4	$272K	Buy	2,275 +170	+8%	+$20.7K	0.03%	195
2017 Q3	$295K	Hold	2,105	–	–	0.04%	174
2017 Q2	$256K	Sell	2,105 -5	-0.2%	-$582	0.03%	183
2017 Q1	$256K	Hold	2,110	–	–	0.03%	174
2016 Q4	$258K	Buy	2,110 +5	+0.2%	+$612	0.03%	163
2016 Q3	$258K	Hold	2,105	–	–	0.03%	165
2016 Q2	$246K	Sell	2,105 -1,500	-42%	-$213K	0.03%	180
2016 Q1	$502K	Buy	3,605 +163	+5%	+$23.9K	0.07%	115
2015 Q4	$657K	Buy	3,442 +87	+3%	+$15.2K	0.09%	103
2015 Q3	$525K	Buy	3,355 +671	+25%	+$122K	0.08%	108
2015 Q2	$485K	Buy	2,684 +544	+25%	+$93.9K	0.06%	174
2015 Q1	$371K	Buy	2,140 +35	+2%	+$6.33K	0.05%	193
2014 Q4	$389K	Hold	2,105	–	–	0.06%	136
2014 Q3	$349K	Sell	2,105 -405	-16%	-$66.5K	0.05%	170
2014 Q2	$392K	Sell	2,510 -550	-18%	-$86.8K	0.06%	162
2014 Q1	$466K	Buy	3,060 +1,305	+74%	+$208K	0.07%	148
2013 Q4	$233K	Buy	+1,755	New	+$211K	0.04%	203